PL3313408T3 - Środek antykoncepcyjny na bazie drospirenonu dla pacjentki z nadmierną wagą - Google Patents

Środek antykoncepcyjny na bazie drospirenonu dla pacjentki z nadmierną wagą

Info

Publication number
PL3313408T3
PL3313408T3 PL16731177.8T PL16731177T PL3313408T3 PL 3313408 T3 PL3313408 T3 PL 3313408T3 PL 16731177 T PL16731177 T PL 16731177T PL 3313408 T3 PL3313408 T3 PL 3313408T3
Authority
PL
Poland
Prior art keywords
drospirenone
female patient
excess weight
patient affected
based contraceptive
Prior art date
Application number
PL16731177.8T
Other languages
English (en)
Polish (pl)
Inventor
Dominique Drouin
Cécile BOYER-JOUBERT
Philippe Perrin
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3313408(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of PL3313408T3 publication Critical patent/PL3313408T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL16731177.8T 2015-06-23 2016-06-23 Środek antykoncepcyjny na bazie drospirenonu dla pacjentki z nadmierną wagą PL3313408T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (1)

Publication Number Publication Date
PL3313408T3 true PL3313408T3 (pl) 2024-04-15

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16731177.8T PL3313408T3 (pl) 2015-06-23 2016-06-23 Środek antykoncepcyjny na bazie drospirenonu dla pacjentki z nadmierną wagą

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN113750108B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
WO2016203044A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
DK3313408T3 (da) 2015-06-23 2024-01-29 Laboratorios Leon Farma Sa Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
AU2002368326A1 (en) * 2002-11-05 2004-06-07 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20060009428A1 (en) * 2004-07-07 2006-01-12 Wyeth Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
PT1746101E (pt) 2005-07-21 2008-10-27 Bayer Schering Pharma Ag Processo para o fabrico de 3-oxo-pregn-4-eno-21,17-carbolactonas por meio de oxidação isenta de metais de 17-(3-hidroxipropil)-3,17-di-hidroxiandrostanos
BRPI0810049A2 (pt) * 2007-04-05 2015-05-05 Bayer Schering Pharma Ag Regime de drospirenona/17beta-estradiol, produto de combinação farmacêutica e kit para realizar esse regime
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
DK3313408T3 (da) 2015-06-23 2024-01-29 Laboratorios Leon Farma Sa Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt

Also Published As

Publication number Publication date
EA036497B1 (ru) 2020-11-17
HUE065350T2 (hu) 2024-05-28
UA122873C2 (uk) 2021-01-13
JP2018527305A (ja) 2018-09-20
LT3313408T (lt) 2024-03-12
CA2989975C (en) 2021-10-12
KR20180019173A (ko) 2018-02-23
HK1255216A1 (zh) 2019-08-09
AU2016282863A1 (en) 2018-02-08
SV2017005602A (es) 2018-08-14
SI3313408T1 (sl) 2024-04-30
CA2989975A1 (en) 2016-12-29
HRP20240121T8 (hr) 2024-05-10
NI201700173A (es) 2018-04-02
BR112017028048A2 (pt) 2018-09-04
AU2016282863B2 (en) 2021-05-27
CN113750108B (zh) 2025-08-19
SMT202400062T1 (it) 2024-03-13
CN108025014A (zh) 2018-05-11
MX2017016801A (es) 2018-05-11
ZA201800067B (en) 2019-07-31
HRP20240121T1 (hr) 2024-04-12
MX389310B (es) 2025-03-20
JP6827962B2 (ja) 2021-02-10
FI3313408T3 (fi) 2024-01-25
DK3313408T3 (da) 2024-01-29
ES2970532T3 (es) 2024-05-29
CN108025014B (zh) 2021-10-22
WO2016207298A1 (en) 2016-12-29
NZ739195A (en) 2024-04-26
CN113750108A (zh) 2021-12-07
KR102217942B1 (ko) 2021-02-19
EA201792595A1 (ru) 2018-06-29
MY187233A (en) 2021-09-13
EP3313408B1 (en) 2023-12-06
PH12017502379A1 (en) 2018-06-25
RS65196B1 (sr) 2024-03-29
EP3313408A1 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
IL281584B (en) Expandable gastric retention dosage form
ZA201800067B (en) Drospirenone-based contraceptive for a female patient affected with excess weight
SG10202001239PA (en) Imaging a body
PL3177723T3 (pl) Aptamery do zastosowania przeciwko chorobom związanym z autoprzeciwciałem
SG11201606247QA (en) Antimicrobial inserts for medical devices
GB2539737B (en) Attachment for a wheelchair
GB201508300D0 (en) A prosthesis
GB201505032D0 (en) Orthotic insole
GB2539858B (en) Vaginal insert
ZA201706201B (en) A soft high basis weight tissue
AU366777S (en) Pessary
GB201720992D0 (en) A medical use
GB201508593D0 (en) A stent
GB201517432D0 (en) Splint
GB2550099B (en) Airway stent
GB201518078D0 (en) Model generation for drug determination
GB201407836D0 (en) A condom
PT3313408T (pt) Contracetivo à base de drospirenona para uma paciente do sexo feminino afetada com excesso de peso
PL3065678T3 (pl) Pessarium terapeutyczne
ZA201908327B (en) Weight optimization
GB2544276B (en) Height adjusting wheelchair
GB201521168D0 (en) A weight device
GB2532411B (en) A disposable female urinal
AU363888S (en) A weight
AU363854S (en) A weight